Pulling SEC filings + quote and writing the call…

Atmus Filtration Technologies Inc.
Next earnings Aug 6, 2026 · consensus $0.78 EPS, $515M rev
Last earnings -17.0% on 2026-05-01
Quality filtration compounder at 20x earnings with 54.8% ROE, accelerating FCF and a rapidly deleveraging post-spin balance sheet.
Revenue $1.76B · FY2025
Solid fundamentals at a roughly fair price — reasonable risk/reward at today's level.
Atmus is a high-quality industrial spin-out exhibiting the classic post-IPO flywheel: revenue grew 5.7% to $1.76B in FY2025 while net income jumped 11.7% to $207M and diluted EPS rose 12.6% to $2.50 — operating leverage is real, with operating margin expanding to 16.9% and operating income up 12.3%. The five-year revenue trajectory ($1.44B → $1.76B) is steady rather than spectacular, but profitability is widening faster than the top line, which is exactly what you want from a market-leading filtration franchise serving aftermarket-heavy end markets. ROE of 54.8% is exceptional, and while it is flattered by a still-modest equity base, the equity grew 66.4% YoY as retained earnings climbed 71.9% — the leverage profile is normalizing rapidly without diluting returns.
The balance sheet narrative is the most under-appreciated piece. Cash rose 28.3% to $236M, long-term debt fell 5.3% to $540M, and operating cash flow nearly doubled to $203M (+92.3%) against just $53.9M of capex — that is roughly $149M of free cash flow, ~3.6% FCF yield on the $4.13B market cap with capacity to compound. Management is already returning capital: buybacks tripled to $60.7M and shares outstanding shrank 1.6%. The 10-K explicitly flags that 'substantially all Atmus' assets [are] pledged as security' for the term loan and revolver, so deleveraging is not optional housekeeping — it is the central capital-allocation priority, and the data shows it working.
Is ATMU a buy? The one-page verdict, explained →
High-conviction BUY: a wider spread keeps more of the upside while the short call still cuts cost and decay.
Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $1.44B | $1.56B | $1.63B | $1.67B | $1.76B |
| Gross profit | $349M | $359M | $433M | $462M | $498M |
| Operating income | $214M | $204M | $248M | $266M | $299M |
| Net income | $170M | $170M | $171M | $186M | $207M |
| Diluted EPS | $2.04 | $2.05 | $2.05 | $2.22 | $2.50 |
| Net margin | 11.8% | 10.9% | 10.5% | 11.1% | 11.8% |
10-year statements — income, cash flow, balance sheet & CSV export →
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Reg FD disclosure with exhibits; routine investor materials, no financial impact
Annual meeting voting results disclosed; routine shareholder vote outcomes
Executive officer/director change disclosed; leadership transition event
Q1 2026 10-Q; ongoing margin and cash flow strength continuing FY25 trend
Q1 2026 10-Q; ongoing margin and cash flow strength continuing FY25 trend
2026 proxy: director slate, exec comp and auditor ratification for AGM
FY25 10-K: rev $1.76B, NI $207M +11.7%, OCF $203M +92%, equity +66%
FY25 10-K: rev $1.76B, NI $207M +11.7%, OCF $203M +92%, equity +66%
Reg FD/investor materials filed ahead of earnings; non-financial disclosure
Sources: SEC EDGAR (CIK 0001921963, latest 10-Q filed 2026-05-01) · EODHD · Proprietary analysis · as of 6/25/2026, 1:00:42 PM.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 25, 2026, 9:00 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
Last 90 days: 0 open-market buys · 4 sales
| 2026-06-01 | Swan Renee Chief People Officer | Sell | 2.57K @ $45.25 | $116K |
| 2026-06-01 | Masters Charles Senior Vice President | Sell | 2.89K @ $45.25 | $131K |
| 2026-06-01 | Kienzler Jack Chief Financial Officer | Sell | 5.13K @ $45.25 | $232K |
| 2026-06-01 | Disher Stephanie Chief Executive Officer | Sell | 25.7K @ $45.25 | $1.16M |
| 2026-05-12 | Carpenter Kevin N SVP-Chief Supply Chain Officer | Award | 28.5K | |
| 2026-05-12 | Sharp Heath Director | Award | 2.62K | |
| 2026-05-12 | Macadam Stephen E. Director | Award | 2.62K | |
| 2026-05-12 | Leipold Jane A Director | Award | 2.62K |
| D. E. Shaw & Co. | 1.62M sh | $92.0M |
As of each fund’s latest quarterly 13F — a delayed snapshot, not a live position. All tracked funds →
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
1195 tracked peers · median